Although CD133 has been accepted as a marker for CSCs, however, CD133 expression varies depending on the type of cancer, and it could be expressed on several noninitiating cancer cells as well as several healthy tissues and healthy stem cells (Shmelkov et al., 2008; Zhou et al., 2011). Here, PROM1 is linked to cancer.